Coming of age: the evolving role of circulating tumor DNA in malignant lymphoma

Jan-Michel Heger^{1

2

3}, Sven Borchmann^{1

2

3}

Affiliations

¹ Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Cologne, Germany.
² Cologne Lymphoma Working Group, Cologne, Germany.
³ Cancer Center Cologne Essen (CCCE), Cologne, Germany.

Comment

Jan-Michel Heger et al. Leuk Lymphoma. 2022 Apr.

. 2022 Apr;63(4):768-770.

doi: 10.1080/10428194.2022.2027404. Epub 2022 Jan 12.

Jan-Michel Heger^{1

2

3}, Sven Borchmann^{1

2

3}

¹ Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Cologne, Germany.
² Cologne Lymphoma Working Group, Cologne, Germany.
³ Cancer Center Cologne Essen (CCCE), Cologne, Germany.

No abstract available

Comment on

Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study.
Camus V, Viennot M, Lévêque E, Viailly PJ, Tonnelet D, Veresezan EL, Drieux F, Etancelin P, Dubois S, Stamatoullas A, Tilly H, Bohers E, Jardin F. Camus V, et al. Leuk Lymphoma. 2022 Apr;63(4):834-844. doi: 10.1080/10428194.2021.2010060. Epub 2022 Jan 25. Leuk Lymphoma. 2022. PMID: 35075971